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Summary
PRINCIPLES: Interstitial pregnancy represents 2% of ec-
topic pregnancies, but it is a highly morbid condition with
a 2.5% of maternal mortality. Its diagnostic and therapeutic
management remains controversial. The aim of this review
is to describe the management of interstitial pregnancy in
our institution between 2001 and 2011 and to define some
general rules for the clinical practice.
METHODS: Single institution retrospective study.
RESULTS: Eleven women were treated for interstitial
pregnancy. The median age was 33 years and the median
gestity was 4. Seven patients had a history of gynaecologic-
al surgery and four interstitial pregnancies followed in vitro
fertilisation. The diagnosis was made at a median gesta-
tional age of seven weeks with a median beta-HCG level
of 5,838 U/l. Six of the eleven patients received an initial
treatment with intracornual methotrexate, three with intra-
muscular methotrexate and two with surgery. The median
time to beta-HCG resolution was 58 days. Three of the el-
even patients needed a second line treatment: two after in-
tramuscular methotrexate and one after intracornual metho-
trexate. Six patients had further pregnancies and delivered
by caesarean section.
CONCLUSIONS: A high prevalence of previous ectopic
pregnancies, gynaecological surgery and of pregnancies
resulting from in vitro fertilisation was observed. The earli-
ness of the diagnosis was the factor that allowed a con-
servative treatment in most cases. Beta-HCG level follow
up was fundamental in allowing a second line therapy but
beta-HCG can persist over a long period of time and this
must be taken into account due to its possible psychological
impact. Intracornual methotrexate seems to be more effica-
cious than intramuscular methotrexate in our series.
Key words: interstitial pregnancy; intracornual
methotrexate; intramuscular methotrexate; laparoscopy;
beta-HCG
Introduction
Interstitial pregnancy (IP) is defined as a pregnancy where
the product of conception is implanted in the intramural
portion of the Fallopian tube. It is an uncommon kind of ec-
topic pregnancy (EP) accounting for around 2% of EP, i.e.
one pregnancy for every 2,500–5,000 live births. It can be
differentiated from angular and cornual pregnancy, where
the product of conception is implanted in one of the lat-
eral angles of the uterine cavity, medial to the uterotubal
junction and round ligament, or in a horn of a bicornuate
uterus, respectively. Most of the risk factors for IP are sim-
ilar to those for tubal EP, i.e. a history of pelvic inflam-
matory disease, previous EP, pelvic surgery, smoking and a
conception resulting from infertility treatment techniques.
However, the use of intrauterine device as contraception is
less frequent in patients with IP than in those with tubal or
ovarian EP [1].
IP is a potentially life threatening pathology with a mor-
tality rate of 2.5% [2] due to the risk of rupture in a
highly vascularised area. The majority of ruptures are de-
scribed at around 12 weeks of gestation, but they can
happen between 7 and 12 weeks. This observation makes
early diagnosis very important in order to offer a con-
servative treatment [3]. The aim of this review is to de-
scribe the management of IP in our institution between
2001 and 2011 and to define some general rules for the
clinical practice.
Materials and methods
A single institution retrospective study was conducted at
the University Hospital of Lausanne (CHUV – Centre Hos-
pitalier Universitaire Vaudois), Switzerland. Data on the
diagnosis of IP, its management and patient follow up were
collected from our computerised medical chart (DIAMM).
The diagnosis of IP was made either by transvaginal ultra-
sound (TVUS) or during a surgical diagnostic procedure.
TVUS were performed in order to localise an early preg-
nancy or in case of symptoms, signs and laboratory results
suspicious of EP or miscarriage.
The ultrasonographic criteria as described by Timor-
Tritsch in 1992 [4] and later modified by Bourdel et al. [3]
were used:
1 an eccentric gestational sac (GS) in regard to the uterus
in a sagittal axis (fig. 1);
2 the absence of the double decidual sac sign around the
GS;
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3 less than 5 mm of myometrial layer around the GS
(fig. 1);
4 the interstitial line sign, i.e. the presence of an
echogenic line that joins the endometrial cavity to the
GS in the cornual region.
We analysed the different treatment options, their results
and the need for a second or third line treatment. Medical
data of the different therapies are discussed as well as the
follow up duration and its impact on the therapeutic ap-
proach.
The medical treatment adopted in our institution consis-
ted either in systemic intramuscular Methotrexate (IM-
MTX) injection (1 mg/kg) or direct Methotrexate injec-
tion (1 mg/kg) into the cornual region (IC-MTX) through
laparoscopy or under TVUS, when the patient was hae-
modynamically stable and the pregnancy had been dia-
gnosed as interstitial on TVUS. The follow up then in-
cluded beta-HCG levels at days four and seven after
MTX injection. If the decline of the beta-HCG level was
less than 15% of the pre-MTX value, a second injection
of MTX was performed; otherwise a weekly follow up
was carried out until negativity. After two MTX injec-
tions a rise or a plateau in beta-HCG levels was an indic-
ation for laparoscopy.
When the clinical or haemodynamic condition of the pa-
tient did not allow conservative treatment, laparoscopy al-
lowed cornuectomy or cornuostomy depending on the size
of the IP and clinical situation.
Results
Between 2001 and 2011, 1,334 patients were admitted with
a suspicion of EP of which 758 (56.8%) were confirmed to
have EP. Among these 758 patients, eleven had an IP (1.4%
of EP).
The eleven patients with a diagnosis of IP had a median
age of 33 years (range 25–39). The median gestity was four
(range 1–8) and the median parity was one (range 0–5).
Symptomatic patients consulted the gynaecological outpa-
tient unit for abdominal pain with or without associated
spotting. Abdominal pain ranged from sudden cramps or
sharp pelvic pain to dull abdominal discomfort. Asympto-
Figure 1
TVUS sagittal image showing an eccentric GS, blue arrow,
surrounded by a thin myometrial layer, red arrow.
matic patients were diagnosed with a cornual pregnancy
during a routine ultrasound or, in case of in vitro fertiliz-
ation, because of a suspicion of miscarriage or EP. TVUS
allowed a definitive diagnosis of IP in seven out of 11 cases
(64%), while in all the other cases a diagnostic laparoscop-
ic procedure was necessary for a definitive diagnosis.
The diagnosis was made at a median gestational age of sev-
en weeks (range 5–10 weeks), with a median beta-HCG
level of 5838 U/l (range 2,974–15,022).
With regard to IP risk factors, seven patients (64%) had a
previous history of gynaecological surgery. Four of these
had already had surgery for tubal EP: one case of salpin-
gotomy, two salpingectomy and one had salpingotomy fol-
lowed by a salpingectomy. The last three patients had,
respectively, a left ovariectomy, one laparoscopic myomec-
tomy and a bilateral salpingectomy.
Four of eleven IPs followed in vitro fertilization (IVF).
None of the patients was using an intrauterine device at the
time of the IP.
Nine patients were treated with MTX whereas two had a
cornual resection during a diagnostic laparoscopy, conver-
ted to laparotomy in one case. Three out of nine patients
were treated with intramuscular MTX (IM-MTX) and in
the remaining six MTX was injected directly into the
cornual region (IC-MTX): in four cases during a laparo-
scopy (fig. 2) and in two cases during a transvaginal ultra-
sound procedure.
Figure 2
Laparoscopic intracornual MTX injection.
Figure 3
Beta-HCG level follow up after first, second and third line therapies.
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The follow-up consisted in monitoring the beta-HCG level
decline (fig. 3). The median time to beta-HCG resolution
was 58 days (range 22–132 days). In the six patients treated
with MTX and who did not need a second intervention, the
time to beta-HCG resolution was 58 days for the only pa-
tient treated with IM-MTX and between 22 and 59 days for
the five patients treated with IC-MTX (with a median of 52
days).
Three patients experienced post treatment side effects: one
complained of sharp abdominal pain accompanied by naus-
ea and vomiting on the day of IM-MTX injection and an-
other reported an increase in abdominal pain seven days
after a TVUS-guided IC-MTX. There was no evidence
of uterine rupture in both cases. The third patient exper-
ienced weakness and dizziness the day after laparoscopic
salpingectomy and cornuectomy for a ruptured IP, with a
haemoglobin value of 94 g/l.
One patient asked repeatedly for a definitive surgical ap-
proach because of psychological exhaustion due to the
stagnation of beta-HCG after three doses of IM-MTX ad-
ministered in another institution and a hysteroscopy cur-
ettage performed in order to differentiate from an angular
pregnancy. Another patient treated with IM-MTX needed
a second intervention by curettage in order to treat heavy
bleeding during the expulsion of the gestational sac 86 days
after the IM-MTX injection. One more patient needed a
second line intervention by laparoscopic cornuectomy and
salpingectomy 21 days after laparoscopic IC-MTX because
of a plateau in beta-HCG follow up. No case of cornual
rupture was observed following conservative therapy.
With regard to fertility, six patients had further pregnancies
(nine in total) and gave birth to healthy children in six of
the nine cases. In the three other cases, one patient had
a right tubal EP one year after the right IP, another pa-
tient had a voluntary termination of pregnancy and the
third one has an ongoing pregnancy. Eight out of the nine
pregnancies occurred after conservative treatment by MTX
(either IM-MTX or IC-MTX) and one after cornuectomy.
Three of the six patients needed IVF. All deliveries were by
caesarean section. There were no cases of uterine rupture,
in utero death or other remarkable complications.
Discussion
Six of the eleven patients in our series had at least one of
the risk factors for IP mentioned in the introduction. A high
prevalence of previous EP, gynaecological surgery and of
pregnancies resulting from in vitro fertilization was ob-
served. The in vitro fertilization techniques can either rep-
resent an independent risk factor for IP or simply reflect
the high prevalence of infertility caused by the other risk
factors: indeed in our series all the patients who needed
IVF had an history of previous gynaecological pelvic sur-
gery.
These observations emphasize the importance of early ul-
trasound imaging in patients with a history of possible tubal
damage since IP is often pauci-symptomatic until rupture
occurs. The relatively high median age in our series can
also be related to the high prevalence of prior tubal damage
and the relative high gestity of our patients.
Table 1: Patient characteristics.
N. Year Age Gestity
Parity
Weeks of
Gest.
¥ 1st ttt 2nd ttt 3rd ttt History Later pregnancies
1 2001 30 years 6G5P 6 Spont. IC-MTX/LPS – – R Salpingectomy EP Cesarean 2002
(spont.)
1 voluntary abortion
2004
2 2003 32 years 4G1P 6 Spont. IC-MTX/
TVUS
– – L Ovariectomy
(dermoid cyst)
R EP 2004
Twins- cesarean
2005 (IVF)
3 2006 32 years 6G0P 6 IVF LPS/LPT
cornuectomy
– – R salpingotomy EP
R salpingectomy EP
L salpingectomy EP
Cesarean 2010 (IVF)
4 2007 34 years 1G0P 7 IVF Curettage/IM-
MTX
Curettage
under US
Day-86
– Laparoscopic myomectomy Cesarean 2008
(spont.)
Cesarean 2010
(spont.)
5 2008 39 years 3G0P 9 IVF IM-MTX (3X) HSC-curettage
Day-35
LPS day-42
cornuostomy
L salpingectomy EP
R salpingectomy
hydrosalpinx
Laparoscopic myomectomy
–
6 2009 33 years 4G1P 5 Spont. IC-MTX/LPS – – Cesarean 2010
(spont.)
7 2009 36 years 3G1P 7 Spont. IC-MTX/LPS IM-MTX
Day-7
LPS day-21
cornuectomy and
salpingectomy
– –
8 2009 28 years 1G0P 7 Spont. IM-MTX – – – –
9 2010 25 years 4G1P 9 Spont. IC-MTX/LPS – – L salpingotomy EP –
10 2011 33 years 1G0P 5 IVF IC-MTX/
TVUS
– – Bilateral salpingectomy
hydrosalpinx
Ongoing pregnancy
11 2011 37 years 8G2P 10 Spont. LPS
cornuectomy
– – – –
Gest. = gestation; Spont. = spontaneous; ttt = treatment; IC-MTX = intra cornual methotrexate; LPS = laparoscopy; R = right; EP = ectopic pregnancy; TVUS = trans
vaginal ultrasound; L = left; IVF = in vitro fertilization; LPT = laparotomy; IM-MTX = intra muscular methotrexate; US = ultrasound; HSC = hysteroscopy.
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Although IP is often asymptomatic or pauci-symptomatic,
it can present with symptoms and signs typical of EP, such
as abdominal tenderness (from pelvic discomfort to strong
abdominal pain in case of cornual rupture) associated with
vaginal bleeding, even if this latter sign is less common in
IP than in tubal EP [5]. These observations were confirmed
in our series, where only one patient consulted because of
vaginal bleeding, while five of the eleven presented with
abdominal pain ranging from sudden cramps to dull ab-
dominal discomfort.
IP diagnosis is usually made by TVUS, which is the key to
an accurate localisation of IP. An accurate and early local-
isation of the pregnancy by TVUS is a pre-requisite for a
conservative treatment in asymptomatic or pauci-sympto-
matic patients [6–10] and in our series the earliness of the
diagnosis was the factor that allowed a conservative treat-
ment in the majority of cases. IP diagnosis and its differen-
tiation from angular pregnancy nevertheless remain chal-
lenging and in the literature the ultrasound diagnosis of IP
is accurate in 71.4% of cases [10].
Progress in 3D TVUS makes this technique a good and pre-
cise diagnostic tool. In particular, the 3D reconstruction in
a coronal sectional plane allows localisation of the GS in
relation to the uterine cavity, therefore helping in differen-
tiating the IP from an angular pregnancy [11–13] (fig. 4).
In very specific situations (e.g. in case of obesity, when
TVUS diagnosis can be equivocal) magnetic resonance
imaging (MRI) can be used [3, 14, 15]. None of our pa-
tients needed MRI.
Unlike other kinds of EP, the initial level of beta-HCG in IP
has no real impact on diagnosis and management. The fol-
low up of beta-HCG levels is nevertheless fundamental in
allowing a second line therapy in case of rising or plateau
before the onset of major complications. However, beta-
HCG can persist over a long period of time and this must be
taken into account due to its possible psychological impact
on patients. Furthermore, the length of beta-HCG fall could
make the follow up schedule applied to EP not suitable for
IP. In our series, in two of the three patients who needed a
second line treatment, the decision was based on the plat-
eau of the beta-HCG level. However, in the third patient,
the third line treatment was based more on the kinetic of the
Figure 4
Image showing a left IP 3D reconstruction in a coronal sectional
plane. The blue arrow indicates the lateral GS surrounded by a thin
myometrial layer.
beta-HCG fall, which was estimated to be too slow, than on
the presence of a real plateau. That kinetic was very simil-
ar to those of other patients who did not receive additional
treatments. Possibly the acceptance of a slower rate in beta-
HCG level fall could have avoided a surgical treatment in
this patient. Other studies also reported a long decline in
beta-HCG levels, often exceeding 8 weeks [16, 17].
The treatment of IP depends on many factors, i.e. the clin-
ical conditions of the patient, the wish for future pregnan-
cies, the week of gestation at presentation, the diameter of
the GS, the physician’s experience and the possibility of
performing a long follow up.
A conservative treatment can be performed by IM-MTX
[18] or by intra-cornual MTX through a laparoscopic or
US-controlled vaginal approach [19–21]. IM-MTX allows
successful treatment without the need for an additional
procedure in 80–94% of cases [7, 18] thus lowering the
cost and the possible complications of surgery, but it is
hampered by the risk of cornual rupture with subsequent
catastrophic haemorrhage [22, 23]. For this reason, a close
follow up and a 24 hour access to medical and surgical care
are necessary. Moreover, the fall in beta-HCG levels seems
to be longer than after IC-MTX injection, as is suggested in
our series. A recently published paper reports the success-
ful management of two IPs with IM-MTX combined with
Mifepristone 600 mg, but the eventual advantages over IM-
MTX alone remain to be established [24].
IC-MTX, through laparoscopy or TVUS-guided procedure,
has a higher success rate than IM-MTX, similar to that of
cornuostomy (86–100%) [7]. On the other hand, it is also
hampered by the risk of cornual rupture, it implies the per-
formance of an associated procedure, including all the con-
sequent risks (anaesthesia, haemorrhages, infections, injur-
ies to other organs), it requires special expertise and the
results are operator dependent. Taking this into account,
IC-MTX should be used when laparoscopy is necessary
to establish the definitive diagnosis and to look for and
eventually treat associated pathologies or complications. In
our series one of six patients treated with IC-MTX and
two of three patients treated by IM-MTX needed a second
and third line treatment, without a significant difference
in the gestational age at diagnosis (between six and nine
weeks). We can thus conclude that in our experience IC-
MTX seems to be more efficacious than IM-MTX and that
IC-MTX under TVUS guidance can be a good alternative
to IM-MTX due to its higher efficacy coupled with the ab-
sence of the risks related to laparoscopy. These observa-
tions confirm those of several other studies [7, 16, 25].
When a second injection of MTX is needed, it is usually
performed IM and can be associated with a selective uter-
ine artery embolization, so as to interrupt the blood supply
and obtain a spontaneous necrosis of IP. This technique
nevertheless remains experimental until more information
on safety and efficacy is gathered [26–28].
It must be noted, however, that the use of MTX, IC or IM,
implies a long follow up of beta-HCG level resolution and
of the patient’s clinical condition. For this reason, the abil-
ity of the patient to show up at follow up controls, her level
of understanding of the danger of her condition and her
psychological compliance must be evaluated and should,
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when possible, be discussed with the patient when choos-
ing the appropriate treatment.
When the patient’s clinical conditions, the persistence of
trophoblastic material or the impossibility of respecting the
follow up protocol do not allow a conservative treatment, a
surgical approach is indicated, with salpingectomy or hys-
terectomy as a last option in case of uncontrolled bleeding
[5]. In our series two of the eleven patients were treated by
cornuectomy as a first line treatment; in the first case a dia-
gnostic laparoscopy was converted to laparotomy because
of persistent bleeding from the ruptured uterine horn and in
the second case a cornuectomy was performed because of
massive bleeding from the ruptured IP. Two other patients
needed a surgical approach after the failure of conservative
management: one could be treated by a laparoscopic cornu-
ostomy while the local conditions of the uterine horn re-
quired a laparoscopic cornuectomy and salpingectomy in
the other patient.
Cornual resection is thus considered the classical interven-
tion, but with pregnancies <40 mm in diameter a simple
linear incision over the interstitial pregnancy and expres-
sion of the gestational tissue (cornuostomy) can be at-
tempted. Laparoscopy is the preferred approach in well
equipped centres with trained surgical and reanimation
teams [8, 29–31].
Different case reports describe techniques to improve hae-
mostasis control during laparoscopic procedures (Endo-
loop, automatic staplers such as Endo GIA Auto Suture,
uterine artery ligation, advanced bipolar coagulation)
[32–36].
The treatment should also aim at preserving fertility, if this
represents the wish of the patient. In our series, all patients
were clinically stable at diagnosis and none needed hys-
terectomy. Five patients had pregnancies after conservative
treatment by MTX and one after cornuectomy. Independ-
ent of the kind of treatment performed all patients were de-
livered by elective caesarean section because of the risk of
uterine rupture [37, 38].
In conclusion, we can recommend conservative treatment
as a first line therapy in those patients who are stable at dia-
gnosis, who can comply with a possibly long follow up and
whose IP has been diagnosed at an early gestational age.
We achieved better results with IC-MTX, which was per-
formed in four of six cases during a laparoscopy. Never-
theless, because of the rarity of IP and the heterogeneity in
managements and treatments, many questions still remain
open. The sensitivity and specificity of currently avail-
able diagnostic tools (TVUS and 3D TVUS) should be in-
creased and the exact role and benefits of TVUS-guided
IC-MTX should be better established. At the same time,
clear and unambiguous attitudes regarding initial treat-
ment, follow up and second line therapy in case of persist-
ent IP need to be defined. Considering the rarity of this
pathology, multicentre studies are required to definitely an-
swer these questions.
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Figures (large format)
Figure 1
TVUS sagittal image showing an eccentric GS, blue arrow, surrounded by a thin myometrial layer, red arrow.
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Figure 2
Laparoscopic intracornual MTX injection.
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Figure 3
Beta-HCG level follow up after first, second and third line therapies.
Figure 4
Image showing a left IP 3D reconstruction in a coronal sectional plane. The blue arrow indicates the lateral GS surrounded by a thin myometrial
layer.
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